首页 › 基金 › EVENTIDE ASSET MANAGEMENT, LLC › KYMR
EVENTIDE ASSET MANAGEMENT, LLC 对 KYMR 的持仓历史
KYMERA THERAPEUTICS INC · 医疗保健
EVENTIDE ASSET MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 KYMR(KYMERA THERAPEUTICS INC)490,611 股,市值约 US$54.8M,约占其申报组合的 0.77%,在其申报持仓中市值排名第 39 位。 EVENTIDE ASSET MANAGEMENT, LLC 最近 11 个申报季度中有 11 个季度披露了 KYMR 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
EVENTIDE ASSET MANAGEMENT, LLC 对 KYMR 的持仓演变
EVENTIDE ASSET MANAGEMENT, LLC 于 Q1 2024 首次披露 KYMR 持仓:19,774 股(约 US$795K)。 该持仓在 Q2 2026 达到峰值 504,210 股,市值约 US$57.8M。 在 11 次申报中,EVENTIDE ASSET MANAGEMENT, LLC 5 次增持、4 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 490,611 股、市值约 US$54.8M,环比减持 -13,599 股。。 持仓曾出现大幅变动:Q2 2024 增持约 2237% (随后一个季度股价上涨 59%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 19.77K | $794.91K | 新进 |
| Q2 2024 | 462.10K | $13.79M | 增持 |
| Q3 2024 | 507.90K | $24.04M | 增持 |
| Q4 2024 | 455.73K | $18.33M | 减持 |
| Q1 2025 | 525.14K | $14.37M | 增持 |
| Q2 2025 | 562.99K | $24.57M | 增持 |
| Q3 2025 | 644.59K | $36.48M | 增持 |
| Q4 2025 | 626.43K | $48.74M | 减持 |
| Q1 2026 | 626.92K | $52.21M | 持有 |
| Q2 2026 | 504.21K | $57.81M | 减持 |
| Q3 2026 | 490.61K | $54.84M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KYMR 与 13F 数据
KYMR(KYMERA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 54 只申报持有 KYMR,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KYMR 的基金
- BAKER BROS. ADVISORS LP 8.66M 股 · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M 股 · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M 股 · $717.52M · Q2 2026
- BVF INC/IL 3.87M 股 · $444.01M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M 股 · $318.33M · Q3 2026
- Siren, L.L.C. 2.78M 股 · $311.32M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K 股 · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K 股 · $86.32M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K 股 · $84.96M · Q2 2026
- Rock Springs Capital Management LP 453.16K 股 · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K 股 · $49.20M · Q2 2026
- BRAIDWELL LP 378.16K 股 · $43.36M · Q2 2026
更多关于 EVENTIDE ASSET MANAGEMENT, LLC
常见问题
How long has EVENTIDE ASSET MANAGEMENT, LLC held KYMR?
EVENTIDE ASSET MANAGEMENT, LLC has disclosed KYMR holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is EVENTIDE ASSET MANAGEMENT, LLC's current position in KYMR?
As of Q3 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 490.61K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $54.84M, representing 0.77% of its reported portfolio and ranking #39.
Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling KYMR?
In the latest 13F filing (Q3 2026), EVENTIDE ASSET MANAGEMENT, LLC reduced its position in KYMR. The position peaked in Q2 2026 at 504.21K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.